EUR 2.47
(0.61%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 46.22 Million EUR | 10.05% |
2022 | 42 Million EUR | -5.5% |
2021 | 44.44 Million EUR | 21.29% |
2020 | 36.64 Million EUR | 146.94% |
2019 | 14.84 Million EUR | 63.89% |
2018 | 9.05 Million EUR | -1.65% |
2017 | 9.2 Million EUR | 17.78% |
2016 | 7.81 Million EUR | 6.99% |
2015 | 7.3 Million EUR | 78.46% |
2014 | 4.09 Million EUR | 880.23% |
2013 | 417.65 Thousand EUR | -14.49% |
2012 | 488.4 Thousand EUR | -90.97% |
2011 | 5.41 Million EUR | -26.18% |
2010 | 7.32 Million EUR | 70.29% |
2009 | 4.3 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 54.81 Million EUR | 0.0% |
2023 Q2 | 38.4 Million EUR | 0.0% |
2023 FY | 46.22 Million EUR | 10.05% |
2023 Q4 | 46.22 Million EUR | 0.0% |
2022 FY | 42 Million EUR | -5.5% |
2022 Q2 | 43.39 Million EUR | 0.0% |
2022 Q4 | 42 Million EUR | 0.0% |
2021 Q2 | 40.38 Million EUR | 0.0% |
2021 Q4 | 44.44 Million EUR | 0.0% |
2021 FY | 44.44 Million EUR | 21.29% |
2020 Q4 | 36.64 Million EUR | 0.0% |
2020 FY | 36.64 Million EUR | 146.94% |
2020 Q2 | 32.53 Million EUR | 0.0% |
2019 Q4 | 14.84 Million EUR | 0.0% |
2019 Q2 | 11.02 Million EUR | 0.0% |
2019 FY | 14.84 Million EUR | 63.89% |
2018 FY | 9.05 Million EUR | -1.65% |
2018 Q4 | 9.05 Million EUR | 0.0% |
2018 Q2 | 8.57 Million EUR | 0.0% |
2017 Q2 | 8.83 Million EUR | 0.0% |
2017 FY | 9.2 Million EUR | 17.78% |
2017 Q4 | 9.2 Million EUR | 0.0% |
2016 FY | 7.81 Million EUR | 6.99% |
2016 Q4 | 7.81 Million EUR | 0.0% |
2016 Q2 | 8.09 Million EUR | 0.0% |
2015 Q4 | 7.3 Million EUR | 0.0% |
2015 Q2 | 6.46 Million EUR | 0.0% |
2015 FY | 7.3 Million EUR | 78.46% |
2014 Q4 | 4.09 Million EUR | 0.0% |
2014 FY | 4.09 Million EUR | 880.23% |
2014 Q2 | 3.95 Million EUR | 0.0% |
2013 Q2 | 2.6 Million EUR | 0.0% |
2013 FY | 417.65 Thousand EUR | -14.49% |
2013 Q4 | 417.65 Thousand EUR | 0.0% |
2012 Q4 | 488.4 Thousand EUR | 0.0% |
2012 Q2 | 2.81 Million EUR | 0.0% |
2012 FY | 488.4 Thousand EUR | -90.97% |
2011 Q4 | 5.41 Million EUR | 0.0% |
2011 FY | 5.41 Million EUR | -26.18% |
2010 FY | 7.32 Million EUR | 70.29% |
2009 FY | 4.3 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Affluent Medical SA | 25.15 Million EUR | -83.802% |
Bluelinea Société Anonyme | 8.86 Million EUR | -421.484% |
Carmat SA | 96.83 Million EUR | 52.259% |
Diagnostic Medical Systems S.A. | 37.41 Million EUR | -23.551% |
Euromedis Groupe | 23.66 Million EUR | -95.327% |
Eurobio Scientific Société anonyme | 141.15 Million EUR | 67.251% |
Ikonisys S.A. | 5.11 Million EUR | -802.899% |
Implanet S.A. | 10.81 Million EUR | -327.602% |
SpineGuard SA | 5 Million EUR | -823.931% |
Theraclion SA | 13.01 Million EUR | -255.147% |
Euroapi S.A. | 684.7 Million EUR | 93.248% |
Guerbet SA | 646.97 Million EUR | 92.855% |